{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:53:55Z","timestamp":1790870035215,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1136\/ard.2008.088138","type":"journal-article","created":{"date-parts":[[2008,4,3]],"date-time":"2008-04-03T01:10:25Z","timestamp":1207185025000},"page":"1174-1177","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["The tumour necrosis factor receptor superfamily member 1b 676T>G polymorphism in relation to response to infliximab and adalimumab treatment and disease severity in rheumatoid arthritis"],"prefix":"10.1016","volume":"67","author":[{"given":"E J M","family":"Toonen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M J H","family":"Coenen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Kievit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Fransen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A M","family":"Eijsbouts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Scheffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T R D J","family":"Radstake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M C W","family":"Creemers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D-J R A M","family":"de Rooij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P L C M","family":"van Riel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Franke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Barrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2008.088138_bib1","doi-asserted-by":"crossref","first-page":"761","DOI":"10.2217\/14622416.8.7.761","article-title":"Pharmacogenetics of anti-TNF treatment in patients with rheumatoid arthritis.","volume":"8","author":"Coenen","year":"2007","journal-title":"Pharmacogenomics"},{"key":"10.1136\/ard.2008.088138_bib2","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.drudis.2006.11.013","article-title":"Potential role of pharmacogenetics in anti-TNF treatment of rheumatoid arthritis and Crohn\u00e2\u20ac\u2122s disease.","volume":"12","author":"Kooloos","year":"2007","journal-title":"Drug Discov Today"},{"key":"10.1136\/ard.2008.088138_bib3","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00296-006-0175-7","article-title":"Association of TNF-alpha -308 G\/A polymorphism with responsiveness to TNF-alpha-blockers in rheumatoid arthritis: a meta-analysis.","volume":"27","author":"Lee","year":"2006","journal-title":"Rheumatol Int"},{"key":"10.1136\/ard.2008.088138_bib4","first-page":"1847","article-title":"Tumor necrosis factor-alpha receptor II polymorphism in patients from southern Europe with mild-moderate and severe rheumatoid arthritis.","volume":"29","author":"Fabris","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2008.088138_bib5","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.humimm.2004.06.010","article-title":"Relationship between the tumor necrosis factor receptor II (TNF-RII) gene polymorphism and sTNF-RII plasma levels in healthy controls and in rheumatoid arthritis.","volume":"65","author":"Tolusso","year":"2004","journal-title":"Hum Immunol"},{"key":"10.1136\/ard.2008.088138_bib6","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1002\/art.10101","article-title":"Association between tumor necrosis factor receptor II and familial, but not sporadic, rheumatoid arthritis: evidence for genetic heterogeneity.","volume":"46","author":"Dieude","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2008.088138_bib7","first-page":"1406","article-title":"No association of polymorphisms in the tumor necrosis factor receptor I and receptor II genes with disease severity in rheumatoid arthritis.","volume":"30","author":"Glossop","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2008.088138_bib8","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/art.20113","article-title":"Tumor necrosis factor receptor II gene polymorphism and severity of rheumatoid arthritis.","volume":"50","author":"Constantin","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2008.088138_bib9","doi-asserted-by":"crossref","first-page":"R1227","DOI":"10.1186\/ar1816","article-title":"Polymorphism in the tumour necrosis factor receptor II gene is associated with circulating levels of soluble tumour necrosis factor receptors in rheumatoid arthritis.","volume":"7","author":"Glossop","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/ard.2008.088138_bib10","doi-asserted-by":"crossref","first-page":"14608","DOI":"10.1074\/jbc.275.19.14608","article-title":"Functional analysis of the domain structure of tumor necrosis factor-alpha converting enzyme.","volume":"275","author":"Reddy","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1136\/ard.2008.088138_bib11","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1002\/art.1780360807","article-title":"Circulating soluble tumor necrosis factor receptors, interleukin-2 receptors, tumor necrosis factor alpha, and interleukin-6 levels in rheumatoid arthritis. Longitudinal evaluation during methotrexate and azathioprine therapy.","volume":"36","author":"Barrera","year":"1993","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2008.088138_bib12","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1002\/art.1780351008","article-title":"Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseases.","volume":"35","author":"Cope","year":"1992","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2008.088138_bib13","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/ard.62.6.526","article-title":"Genetic markers for the efficacy of tumour necrosis factor blocking therapy in rheumatoid arthritis.","volume":"62","author":"Padyukov","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2008.088138_bib14","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2008.088138_bib15","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1136\/ard.2007.072447","article-title":"The efficacy of anti-TNF in rheumatoid arthritis, a comparison between randomized controlled trials and clinical practice.","volume":"66","author":"Kievit","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2008.088138_bib16","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/art.1780390105","volume":"39","author":"van Gestel","year":"1996","journal-title":"Arthritis Rheum"},{"issue":"Suppl","key":"10.1136\/ard.2008.088138_bib17","first-page":"14","article-title":"The Nijmegen inception cohort of early rheumatoid arthritis.","volume":"69","author":"Welsing","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2008.088138_bib18","first-page":"2094","article-title":"A new method of scoring radiographic change in rheumatoid arthritis.","volume":"25","author":"Rau","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2008.088138_bib19","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1034\/j.1399-0039.2000.550122.x","article-title":"Tumor necrosis factor receptor II (TNFRII) exon 6 polymorphism in systemic lupus erythematosus.","volume":"55","author":"al Ansari","year":"2000","journal-title":"Tissue Antigens"},{"key":"10.1136\/ard.2008.088138_bib20","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/ng749","article-title":"Replication validity of genetic association studies.","volume":"29","author":"Ioannidis","year":"2001","journal-title":"Nat Genet"},{"key":"10.1136\/ard.2008.088138_bib21","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.autrev.2007.03.003","article-title":"Biological and clinical effects of anti-TNFalpha treatment.","volume":"7","author":"Valesini","year":"2007","journal-title":"Autoimmun Rev"},{"key":"10.1136\/ard.2008.088138_bib22","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1093\/rheumatology\/kem041","article-title":"Combined tumour necrosis factor-{alpha} and tumour necrosis factor receptor genotypes could predict rheumatoid arthritis patients\u00e2\u20ac\u2122 response to anti-TNF-{alpha} therapy and explain controversies of studies based on a single polymorphism.","volume":"46","author":"Chatzikyriakidou","year":"2007","journal-title":"Rheumatology (Oxford)"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000349672438642X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000349672438642X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2008.088138","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T02:50:12Z","timestamp":1736131812000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000349672438642X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":22,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["S000349672438642X"],"URL":"https:\/\/doi.org\/10.1136\/ard.2008.088138","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The tumour necrosis factor receptor superfamily member 1b 676T>G polymorphism in relation to response to infliximab and adalimumab treatment and disease severity in rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2008.088138","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 2008 Published by Elsevier Inc. Publishing Group and European League Against Rheumatism. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}